巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Phio Pharmaceuticals Corp

PHIO
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Phio Pharmaceuticals Corp - 延遲價格・最後更新於 20/01 12:15
最高位
0.880
最低位
0.880
開市價
--
前收市價
0.876
成交量(千)
1.00
成交額(百萬)
0.01
買入
--
賣出
--
每手股數
--
市值(百萬)
11.91
市盈率
--
息率
--
差價
--
52週高低
4.360 - 0.813
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Phio Pharmaceuticals Corp
證券代碼
PHIO.US
所屬板塊
Biotechnology
公司業務
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.
發行量
13531941
公司總部
257 Simarano Drive, Suite 101
公司網址
https://www.phiopharma.com
公司電郵
tmcgrillen@rxipharma.com
公司電話
+1 508 767-3861
暫無內容

關於

Phio Pharmaceuticals Corp(PHIO.US)所屬的行業板塊為Biotechnology。
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.
詳細公司背景可參考: https://www.phiopharma.com